{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:37:32Z","timestamp":1794980252348,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-020-0569-y","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T16:03:58Z","timestamp":1592841838000},"page":"801-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin"],"prefix":"10.1038","volume":"4","author":[{"given":"Mari","family":"Saif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9474-6695","authenticated-orcid":false,"given":"Wilhelmus J.","family":"Kwanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampurna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Softic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ronald","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"van Leyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver T.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-3548","authenticated-orcid":false,"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-4365","authenticated-orcid":false,"given":"Moungi G.","family":"Bawendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"569_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"569_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"569_CR3","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward, Z. J. et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N. Engl. J. Med. 381, 2440\u20132450 (2019).","journal-title":"N. Engl. J. Med."},{"key":"569_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0035-1562943","volume":"35","author":"SK Satapathy","year":"2015","unstructured":"Satapathy, S. K. & Sanyal, A. J. Epidemiology and natural history of nonalcoholic fatty liver disease. Semin. Liver Dis. 35, 221\u2013235 (2015).","journal-title":"Semin. Liver Dis."},{"key":"569_CR5","doi-asserted-by":"crossref","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Primers 1, 15080 (2015).","DOI":"10.1038\/nrdp.2015.80"},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/hep.29111","volume":"65","author":"DE Kleiner","year":"2017","unstructured":"Kleiner, D. E. On beyond staging and grading: liver biopsy evaluation in a posttreatment world. Hepatology 65, 1432\u20131434 (2017).","journal-title":"Hepatology"},{"key":"569_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C. & Smith, A. D. Liver biopsy. Hepatology 49, 1017\u20131044 (2009).","journal-title":"Hepatology"},{"key":"569_CR8","first-page":"e16","volume":"38","author":"CF Dietrich","year":"2017","unstructured":"Dietrich, C. F. et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography. Ultraschall Med. 38, e16\u2013e47 (2017).","journal-title":"Ultraschall Med."},{"key":"569_CR9","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","volume":"2018","author":"M Masarone","year":"2018","unstructured":"Masarone, M. et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid. Med. Cell. Longev. 2018, 9547613 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"569_CR10","doi-asserted-by":"crossref","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest. 127, 55\u201364 (2017).","DOI":"10.1172\/JCI88881"},{"issue":"Suppl. 1","key":"569_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/liv.13682","volume":"38","author":"P Marcellin","year":"2018","unstructured":"Marcellin, P. & Kutala, B. K. Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 38(Suppl. 1), 2\u20136 (2018).","journal-title":"Liver Int."},{"key":"569_CR12","unstructured":"Vishwanath, K. & Ramanujam, N. in Encyclopedia of Analytical Chemistry (ed. Meyers, R.A.) 20\u201356 (John Wiley & Sons, 2011)."},{"key":"569_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/liv.13753","volume":"38","author":"AC Croce","year":"2018","unstructured":"Croce, A. C., Ferrigno, A., Bottiroli, G. & Vairetti, M. Autofluorescence-based optical biopsy: an effective diagnostic tool in hepatology. Liver Int. 38, 1160\u20131174 (2018).","journal-title":"Liver Int."},{"key":"569_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1387-2656(05)11007-2","volume":"11","author":"M Monici","year":"2005","unstructured":"Monici, M. Cell and tissue autofluorescence research and diagnostic applications. Biotechnol. Annu. Rev. 11, 227\u2013256 (2005).","journal-title":"Biotechnol. Annu. Rev."},{"key":"569_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.cbpa.2003.08.007","volume":"7","author":"JV Frangioni","year":"2003","unstructured":"Frangioni, J. V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7, 626\u2013634 (2003).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"569_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1364\/OL.27.000333","volume":"27","author":"V Ntziachristos","year":"2002","unstructured":"Ntziachristos, V., Ripoll, J. & Weissleder, R. Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt. Lett. 27, 333\u2013335 (2002).","journal-title":"Opt. Lett."},{"key":"569_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1162\/153535003765276282","volume":"2","author":"YT Lim","year":"2003","unstructured":"Lim, Y. T. et al. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol. Imaging 2, 50\u201364 (2003).","journal-title":"Mol. Imaging"},{"key":"569_CR18","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1073\/pnas.1718917115","volume":"115","author":"JA Carr","year":"2018","unstructured":"Carr, J. A. et al. Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green. Proc. Natl Acad. Sci. USA 115, 4465\u20134470 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"569_CR19","doi-asserted-by":"publisher","first-page":"0056","DOI":"10.1038\/s41551-017-0056","volume":"1","author":"OT Bruns","year":"2017","unstructured":"Bruns, O. T. et al. Next-generation in vivo optical imaging with short-wave infrared quantum dots. Nat. Biomed. Eng. 1, 0056 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"569_CR20","doi-asserted-by":"publisher","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","volume":"111","author":"K Iwaisako","year":"2014","unstructured":"Iwaisako, K. et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc. Natl Acad. Sci. USA 111, E3297\u2013E3305 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"569_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.14218\/JCTH.2014.00035","volume":"3","author":"B Delire","year":"2015","unstructured":"Delire, B., St\u00e4rkel, P. & Leclercq, I. Animal models for fibrotic liver diseases: what we have, what we need, and what is under development. J. Clin. Transl. Hepatol. 3, 53\u201366 (2015).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"569_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten, D., Trebicka, J., Liedtke, C. & Weiskirchen, R. The carbon tetrachloride model in mice. Lab. Anim. 49, 4\u201311 (2015).","journal-title":"Lab. Anim."},{"key":"569_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2613.2008.00597.x","volume":"89","author":"AM Geerts","year":"2008","unstructured":"Geerts, A. M. et al. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. Int. J. Exp. Pathol. 89, 251\u2013263 (2008).","journal-title":"Int. J. Exp. Pathol."},{"key":"569_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0023677214567748","volume":"49","author":"C Tag","year":"2015","unstructured":"Tag, C. et al. Induction of experimental obstructive cholestasis in mice. Lab. Anim. 49, 70\u201380 (2015).","journal-title":"Lab. Anim."},{"key":"569_CR25","unstructured":"Majno, G. & Joris, I. in Cells, Tissues, and Disease: Principles of General Pathology (eds Majno, G. & Joris, I.) 74\u2013128 (Oxford University Press, 2004)."},{"key":"569_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.biocel.2003.08.009","volume":"36","author":"A Terman","year":"2004","unstructured":"Terman, A. & Brunk, U. T. Lipofuscin. Int. J. Biochem. Cell Biol. 36, 1400\u20131404 (2004).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"569_CR27","doi-asserted-by":"publisher","first-page":"9298","DOI":"10.1073\/pnas.1604780113","volume":"113","author":"P Rantakari","year":"2016","unstructured":"Rantakari, P. et al. Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury. Proc. Natl Acad. Sci. USA 113, 9298\u20139303 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"569_CR28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1177\/34.10.3745907","volume":"34","author":"H Barden","year":"1986","unstructured":"Barden, H. The intragranular location of carboxyl groups in neuromelanin and lipofuscin in human brain and in meningeal melanosomes in mouse brain. J. Histochem. Cytochem. 34, 1271\u20131279 (1986).","journal-title":"J. Histochem. Cytochem."},{"key":"569_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/10520295609113795","volume":"31","author":"RD Lillie","year":"1956","unstructured":"Lillie, R. D. A Nile blue staining technic for the differentiation of melanin and lipofuscins. Stain Technol. 31, 151\u2013153 (1956).","journal-title":"Stain Technol."},{"key":"569_CR30","doi-asserted-by":"crossref","unstructured":"Evangelou, K. & Gorgoulis, V. G. in Oncogene-Induced Senescence: Methods and Protocols, Methods in Molecular Biology Vol. 1534 (ed. Nikiforov, M.) 111\u2013119 (Humana Press, 2017).","DOI":"10.1007\/978-1-4939-6670-7_10"},{"key":"569_CR31","unstructured":"Everson Pearse, A. G. in Histochemistry Theoretical and Applied Vol. 2, 898\u2013928 (Churchill Livingstone, 1985)."},{"key":"569_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/ars.2009.2598","volume":"12","author":"A Terman","year":"2010","unstructured":"Terman, A., Kurz, T., Navratil, M., Arriaga, E. A. & Brunk, U. T. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial\u2013lysosomal axis theory of aging. Antioxid. Redox Signal. 12, 503\u2013535 (2010).","journal-title":"Antioxid. Redox Signal."},{"key":"569_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2005.12.006","volume":"27","author":"SS Seehafer","year":"2006","unstructured":"Seehafer, S. S. & Pearce, D. A. You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol. Aging 27, 576\u2013588 (2006).","journal-title":"Neurobiol. Aging"},{"key":"569_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/002215549904700601","volume":"47","author":"SA Schnell","year":"1999","unstructured":"Schnell, S. A., Staines, W. A. & Wessendorf, M. W. Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J. Histochem. Cytochem. 47, 719\u2013730 (1999).","journal-title":"J. Histochem. Cytochem."},{"key":"569_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/his.12935","volume":"69","author":"T Erben","year":"2016","unstructured":"Erben, T., Ossig, R., Naim, H. Y. & Schnekenburger, J. What to do with high autofluorescence background in pancreatic tissues\u2014an efficient Sudan black B quenching method for specific immunofluorescence labelling. Histopathology 69, 406\u2013422 (2016).","journal-title":"Histopathology"},{"key":"569_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29370-1","volume":"8","author":"SS Nazeer","year":"2018","unstructured":"Nazeer, S. S., Saraswathy, A., Shenoy, S. J. & Jayasree, R. S. Fluorescence spectroscopy as an efficient tool for staging the degree of liver fibrosis: an in vivo comparison with MRI. Sci. Rep. 8, 10967 (2018).","journal-title":"Sci. Rep."},{"key":"569_CR37","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.1201840109","volume":"109","author":"T Kisseleva","year":"2012","unstructured":"Kisseleva, T. et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl Acad. Sci. USA 109, 9448\u20139453 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"569_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield, J. S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56\u201365 (2005).","journal-title":"J. Clin. Invest."},{"key":"569_CR39","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/labinvest.2010.123","volume":"90","author":"C Liu","year":"2010","unstructured":"Liu, C. et al. Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab. Invest. 90, 1805\u20131816 (2010).","journal-title":"Lab. Invest."},{"key":"569_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fimmu.2014.00430","volume":"5","author":"L Beljaars","year":"2014","unstructured":"Beljaars, L. et al. Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans. Front. Immunol. 5, 430 (2014).","journal-title":"Front. Immunol."},{"key":"569_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto, M. et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int. J. Exp. Pathol. 94, 93\u2013103 (2013).","journal-title":"Int. J. Exp. Pathol."},{"key":"569_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jmor.10287","volume":"263","author":"F Giannessi","year":"2005","unstructured":"Giannessi, F., Giambelluca, M. A., Scavuzzo, M. C. & Ruffoli, R. Ultrastructure of testicular macrophages in aging mice. J. Morphol. 263, 39\u201346 (2005).","journal-title":"J. Morphol."},{"key":"569_CR43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1530\/rep.1.00092","volume":"127","author":"M Jara","year":"2004","unstructured":"Jara, M., Carballada, R. & Esponda, P. Age-induced apoptosis in the male genital tract of the mouse. Reproduction 127, 359\u2013366 (2004).","journal-title":"Reproduction"},{"key":"569_CR44","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0891-5849(02)00959-0","volume":"33","author":"UT Brunk","year":"2002","unstructured":"Brunk, U. T. & Terman, A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 33, 611\u2013619 (2002).","journal-title":"Free Radic. Biol. Med."},{"key":"569_CR45","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2337\/db16-0213","volume":"65","author":"S Softic","year":"2016","unstructured":"Softic, S. et al. Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD. Diabetes 65, 2187\u20132200 (2016).","journal-title":"Diabetes"},{"key":"569_CR46","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"569_CR47","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","volume":"152","author":"C Alonso","year":"2017","unstructured":"Alonso, C. et al. Metabolomic identification of subtypes of nonalcoholic steatohepatitis. Gastroenterology 152, 1449\u20131461 (2017).","journal-title":"Gastroenterology"},{"key":"569_CR48","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt, E. M., Janney, C. G., Bisceglie, A. M. Di, Neuschwander-Tetri, B. A. & Bacon, B. R. Nonalcoholic steatohepatitis\u2014a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467\u20132474 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"569_CR49","doi-asserted-by":"crossref","unstructured":"Orchard, G.E., in Bancroft\u2019s Theory and Practice of Histological Techniques (eds Suvarna, S. K., Layton, C. et al.) 239\u2013270 (Elsevier, 2013).","DOI":"10.1016\/B978-0-7020-4226-3.00013-5"},{"key":"569_CR50","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"569_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-59745-245-8_2","volume":"456","author":"L Casteilla","year":"2008","unstructured":"Casteilla, L., P\u00e9nicaud, L., Cousin, B. & Calise, D. Choosing an adipose tissue depot for sampling: factors in selection and depot specificity. Methods Mol. Biol. 456, 23\u201338 (2008).","journal-title":"Methods Mol. Biol."},{"key":"569_CR52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"}],"updated-by":[{"DOI":"10.1038\/s41551-020-00664-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000}}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0569-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T03:46:26Z","timestamp":1670298386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0569-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1038\/s41551-020-0569-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41551-020-00664-y","asserted-by":"object"}]},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"21 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41551-020-00664-y","URL":"https:\/\/doi.org\/10.1038\/s41551-020-00664-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.P. is an investigator for Bayer, BMS and Lilly; a consultant for Bayer, BMS, Ipsen, Eisai and Lilly; and has received speaker honoraria from Bayer, BMS, Eisai and MSD as well as travel support from Bayer and BMS. R.K.J. received honorarium from Amgen; consultant fees from Chugai, Merck, Ophthotech, Pfizer, SPARC, SynDevRx and XTuit; owns equity in Enlight, Ophthotech, SynDevRx; and serves on the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. M.G.B. is a consultant and owns equity in Lumicell Inc. Neither any reagent nor any funding from these organizations was used in this study. MIT and MGH have filed a patent (United States application no. 62\/654,665; international application no. PCT\/US2019\/026550) based on some of the findings described in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}